NF-kappa B modulation is involved in celastrol induced human multiple myeloma cell apoptosis.

Celastrol is an active compound extracted from the root bark of the traditional Chinese medicine Tripterygium wilfordii Hook F. To investigate the effect of celastrol on human multiple myeloma cell cycle arrest and apoptosis and explore its molecular mechanism of action. The activity of celastrol on LP-1 cell proliferation was detected by WST-8 assay. The celastrol-induced cell cycle arrest was analyzed by flow cytometry after propidium iodide staining. Nuclear translocation of the nuclear factor kappa B (NF-κB) was observed by fluorescence microscope. Celastrol inhibited cell proliferation of LP-1 myeloma cell in a dose-dependent manner with IC50 values of 0.8817 µM, which was mediated through G1 cell cycle arrest and p27 induction. Celastrol induced apoptosis in LP-1 and RPMI 8226 myeloma cells in a time and dose dependent manner, and it involved Caspase-3 activation and NF-κB pathway. Celastrol down-modulated antiapoptotic proteins including Bcl-2 and survivin expression. The expression of NF-κB and IKKa were decreased after celastrol treatment. Celastrol effectively blocked the nuclear translocation of the p65 subunit and induced human multiple myeloma cell cycle arrest and apoptosis by p27 upregulation and NF-kB modulation. It has been demonstrated that the effect of celastrol on NF-kB was HO-1-independent by using zinc protoporphyrin-9 (ZnPPIX), a selective heme oxygenase inhibitor. From the results, it could be inferred that celastrol may be used as a NF-kB inhibitor to inhibit myeloma cell proliferation..

Medienart:

E-Artikel

Erscheinungsjahr:

2014

Erschienen:

2014

Enthalten in:

Zur Gesamtaufnahme - volume:9

Enthalten in:

PLoS ONE - 9(2014), 4, p e95846

Sprache:

Englisch

Beteiligte Personen:

Haiwen Ni [VerfasserIn]
Wanzhou Zhao [VerfasserIn]
Xiangtu Kong [VerfasserIn]
Haitao Li [VerfasserIn]
Jian Ouyang [VerfasserIn]

Links:

doi.org [kostenfrei]
doaj.org [kostenfrei]
europepmc.org [kostenfrei]
Journal toc [kostenfrei]

Themen:

Medicine
Q
R
Science

doi:

10.1371/journal.pone.0095846

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

DOAJ046211020